• en
  • it
  • de
  • Statement regarding supply situation in light of the current Corona Virus outbreak

    To Whom it may concern The Corona Virus outbreak has triggered a number of emergency measures across China, though the Epicenter is only in the Wuhan / Hubei region. Due to this, most parts of China have extended holidays till Feb. 10th, 2020, some places even until Feb. 16th, 2020 as a precautionary measure. Due […]

    Farmabios Breaks Ground to Expand its Manufacturing Footprint in Gropello Cairoli (Italy)

    As part of an ongoing investment program to enhance PharmaZell Group’s production output, we have initiated the construction of a brand new large steroid building and a new warehouse on the Farmabios premises in Gropello Cairoli (Italy). Construction work began in Dec 2019, a symbolic ground breaking ceremony is planned for Mar 2020. The investment […]

    Farmabios expands its portfolio with Cannabidiol API

    Global API supplier Farmabios announced today the addition of an ultra-pure synthetic Cannabidiol (CBD) drug substance to its portfolio. With an EU Drug Master File and cGMP manufacturing capacities, Farmabios is now positioned to fulfill a secure and scalable supply of CBD, from clinical needs to full-scale commercial operations. “As a long-standing supplier of specialized […]